Case report: A novel reciprocal ROS1-CD74 fusion in a NSCLC patient partially benefited from sequential tyrosine kinase inhibitors treatment

BACKGROUND: The clinical significance of majority oncogenic novel fusions is still unknown due to scarcity. Reciprocal ROS1 translocation is a rare form of ROS1 fusion and has not yet been clearly analyzed. CASE PRESENTATION: A 44-year-old Chinese woman with a large dimension in the left lobe of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xugang, Wang, Baoming, Wang, Chunyang, Liao, Chengde, Wang, Shiping, Cao, Ran, Ma, Tonghui, Wang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659814/
https://www.ncbi.nlm.nih.gov/pubmed/36387218
http://dx.doi.org/10.3389/fonc.2022.1021342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659814/
https://www.ncbi.nlm.nih.gov/pubmed/36387218
http://dx.doi.org/10.3389/fonc.2022.1021342

Ejemplares similares